{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:12:11Z","timestamp":1782141131259,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/18682-3"],"award-info":[{"award-number":["2014\/18682-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Trypanosoma cruzi<\/jats:italic>is the causative agent of Chagas disease, which is endemic to subtropical and tropical Americas. The disease treatment remains partially ineffective, involving therapies directed to the parasite as well as palliative strategies for the clinical manifestations. Therefore, novel candidates for disease control are necessary. Additionally, strategies based on parasite inhibition<jats:italic>via<\/jats:italic>specific targets and application of compounds which improve the immune response against the disease is welcomed. Ghrelin is a peptide hormone pointed as a substance with important cardioprotective, vasodilatory, anti-apoptotic, anti-oxidative and immune modulatory functions. The aims of this study were to evaluate the immunomodulatory effects of ghrelin in male Wistar rats infected with the Y strain of<jats:italic>T. cruzi<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In order to delineate an immune response against<jats:italic>T. cruzi<\/jats:italic>mediated by ghrelin, we evaluated the following parameters: quantification of blood and cardiac parasites; analysis of cell markers (CD3<jats:sup>+<\/jats:sup>, CD8<jats:sup>+<\/jats:sup>, NK, NKT, CD45RA<jats:sup>+<\/jats:sup>, macrophage and RT1B<jats:sup>+<\/jats:sup>); nitric oxide (NO) production; lymphoproliferation assays; splenocyte apoptosis; and INF-\u03b3, IL-12 and IL-6 quantification in sera.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The animals infected with<jats:italic>T. cruzi<\/jats:italic>and supplemented with ghrelin demonstrated an upregulated pattern in macrophage and NO production, whereas an anti-inflammatory response was observed in T cells and cytokines. The low response against<jats:italic>T. cruzi<\/jats:italic>mediated by T cells probably contributed to a higher colonization of the cardiac tissue, when compared to infected groups. On the other side, the peptide decreased the inflammatory infiltration in cardiac tissue infected with<jats:italic>T. cruzi<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Ghrelin demonstrated a dual function in animals infected with<jats:italic>T. cruzi<\/jats:italic>. Further studies, especially related to the decrease of cardiac tissue inflammation, are needed in order to determine the advantages of ghrelin supplementation in Chagas disease, mostly for populations from endemic areas.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-019-3787-y","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T13:02:47Z","timestamp":1573304567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of ghrelin supplementation on the acute phase of Chagas disease in rats"],"prefix":"10.1186","volume":"12","author":[{"given":"Ferdinando","family":"de Paula Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2860-4290","authenticated-orcid":false,"given":"C\u00e1ssia Mariana Bronzon","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Miguel","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Fernando Silva","family":"Lessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrius Leonardo","family":"Pitol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo Mardegan","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Cl\u00f3vis","family":"do Prado J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Am\u00e9lia Carraro","family":"Abrah\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"3787_CR1","unstructured":"WHO. Chagas disease (American-trypanosomiasis). Geneva: World Health Organization. 2018. http:\/\/www.who.int\/mediacentre\/factsheets\/fs340\/en\/ . Acessed 20 Feb 2018."},{"key":"3787_CR2","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/nature09221","volume":"465","author":"JR Coura","year":"2010","unstructured":"Coura JR, Vinas PA. Chagas disease: a new worldwide challenge. Nature. 2010;465:S6\u20137.","journal-title":"Nature."},{"key":"3787_CR3","doi-asserted-by":"publisher","first-page":"489758","DOI":"10.1155\/2015\/489758","volume":"2015","author":"O Rodriguez-Morales","year":"2015","unstructured":"Rodriguez-Morales O, Monteon-Padilla V, Carrillo-Sanchez SC, Rios-Castro M, Martinez-Cruz M, Carabarin-Lima A, et al. Experimental vaccines against Chagas disease: a journey through history. J Immunol Res. 2015;2015:489758.","journal-title":"J Immunol Res."},{"key":"3787_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.4161\/hv.7.11.17016","volume":"7","author":"I Quijano-Hernandez","year":"2011","unstructured":"Quijano-Hernandez I, Dumonteil E. Advances and challenges towards a vaccine against Chagas disease. Hum Vaccin. 2011;7:1184\u201391.","journal-title":"Hum Vaccin."},{"key":"3787_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1590\/0074-0276140156","volume":"109","author":"B Zingales","year":"2014","unstructured":"Zingales B, Miles MA, Moraes CB, Luquetti A, Guhl F, Schijman AG, et al. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity. Mem Inst Oswaldo Cruz. 2014;109:828\u201333.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"3787_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","volume":"15","author":"MC Field","year":"2017","unstructured":"Field MC, Horn D, Fairlamb AH, Ferguson MA, Gray DW, Read KD, et al. Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol. 2017;15:217\u201331.","journal-title":"Nat Rev Microbiol."},{"key":"3787_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","volume":"97","author":"PA Sales Junior","year":"2017","unstructured":"Sales Junior PA, Molina I, Fonseca Murta SM, Sanchez-Montalva A, Salvador F, Correa-Oliveira R, et al. Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg. 2017;97:1289\u2013303.","journal-title":"Am J Trop Med Hyg."},{"key":"3787_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature."},{"key":"3787_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.physbeh.2014.04.025","volume":"136","author":"KS Burger","year":"2014","unstructured":"Burger KS, Berner LA. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav. 2014;136:121\u20137.","journal-title":"Physiol Behav."},{"key":"3787_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbi.2011.08.009","volume":"26","author":"D Stevanovic","year":"2012","unstructured":"Stevanovic D, Starcevic V, Vilimanovich U, Nesic D, Vucicevic L, Misirkic M, et al. Immunomodulatory actions of central ghrelin in diet-induced energy imbalance. Brain Behav Immun. 2012;26:150\u20138.","journal-title":"Brain Behav Immun."},{"key":"3787_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2826.2008.01745.x","volume":"20","author":"B Kola","year":"2008","unstructured":"Kola B. Role of AMP-activated protein kinase in the control of appetite. J Neuroendocrinol. 2008;20:942\u201351.","journal-title":"J Neuroendocrinol."},{"key":"3787_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00005-014-0287-9","volume":"62","author":"F Prodam","year":"2014","unstructured":"Prodam F, Filigheddu N. Ghrelin gene products in acute and chronic inflammation. Arch Immunol Ther Exp (Warsz). 2014;62:369\u201384.","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"3787_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI200421134","volume":"114","author":"VD Dixit","year":"2004","unstructured":"Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57\u201366.","journal-title":"J Clin Invest."},{"key":"3787_CR14","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.4049\/jimmunol.0803362","volume":"183","author":"MM Theil","year":"2009","unstructured":"Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H, et al. Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol. 2009;183:2859\u201366.","journal-title":"J Immunol."},{"key":"3787_CR15","doi-asserted-by":"publisher","first-page":"E486","DOI":"10.1152\/ajpendo.00196.2004","volume":"288","author":"M Granado","year":"2005","unstructured":"Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005;288:E486\u201392.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"3787_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.sla.0000251614.42290.ed","volume":"245","author":"R Wu","year":"2007","unstructured":"Wu R, Dong W, Cui X, Zhou M, Simms HH, Ravikumar TS, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg. 2007;245:480\u20136.","journal-title":"Ann Surg."},{"key":"3787_CR17","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1152\/ajpendo.00308.2007","volume":"294","author":"M Granado","year":"2008","unstructured":"Granado M, Martin AI, Lopez-Menduina M, Lopez-Calderon A, Villanua MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am J Physiol Endocrinol Metab. 2008;294:E131\u201341.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"3787_CR18","first-page":"41","volume":"60","author":"PC Konturek","year":"2009","unstructured":"Konturek PC, Brzozowski T, Engel M, Burnat G, Gaca P, Kwiecien S, et al. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol. 2009;60:41\u20137.","journal-title":"J Physiol Pharmacol."},{"key":"3787_CR19","first-page":"561","volume":"54","author":"A Dembinski","year":"2003","unstructured":"Dembinski A, Warzecha Z, Ceranowicz P, Tomaszewska R, Stachura J, Konturek SJ, et al. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol. 2003;54:561\u201373.","journal-title":"J Physiol Pharmacol."},{"key":"3787_CR20","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.3748\/wjg.14.6327","volume":"14","author":"H Osawa","year":"2008","unstructured":"Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol. 2008;14:6327\u201333.","journal-title":"World J Gastroenterol."},{"key":"3787_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.peptides.2008.02.012","volume":"29","author":"O Sehirli","year":"2008","unstructured":"Sehirli O, Sener E, Sener G, Cetinel S, Erzik C, Yegen BC. Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines. Peptides. 2008;29:1231\u201340.","journal-title":"Peptides."},{"key":"3787_CR22","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.peptides.2009.09.004","volume":"30","author":"CX Huang","year":"2009","unstructured":"Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides. 2009;30:2286\u201391.","journal-title":"Peptides."},{"key":"3787_CR23","doi-asserted-by":"publisher","first-page":"e2026","DOI":"10.1371\/journal.pone.0002026","volume":"3","author":"R Wu","year":"2008","unstructured":"Wu R, Dong W, Ji Y, Zhou M, Marini CP, Ravikumar TS, et al. Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS One. 2008;3:e2026.","journal-title":"PLoS One."},{"key":"3787_CR24","doi-asserted-by":"publisher","first-page":"e025","DOI":"10.1590\/1807-3107bor-2019.vol33.0025","volume":"33","author":"M Nokhbehsaim","year":"2019","unstructured":"Nokhbehsaim M, Nogueira AVB, Memmert S, Damanaki A, Eick S, Cirelli JA, et al. Regulation of ghrelin receptor by microbial and inflammatory signals in human osteoblasts. Braz Oral Res. 2019;33:e025.","journal-title":"Braz Oral Res."},{"key":"3787_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1582-4934.2010.01007.x","volume":"14","author":"SB Boscardin","year":"2010","unstructured":"Boscardin SB, Torrecilhas AC, Manarin R, Revelli S, Rey EG, Tonelli RR, et al. Chagas disease: an update on immune mechanisms and therapeutic strategies. J Cell Mol Med. 2010;14:1373\u201384.","journal-title":"J Cell Mol Med."},{"key":"3787_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1590\/S0036-46652010000300012","volume":"52","author":"Neto V Amato","year":"2010","unstructured":"Amato Neto V. Origin of the \u201cY strain\u201d of Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 2010;52:171.","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"3787_CR27","first-page":"191","volume":"20","author":"LHP Silva","year":"1953","unstructured":"Silva LHP, Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folha Cl\u00ednica Biol S\u00e3o Paulo. 1953;20:191\u2013201.","journal-title":"Folha Cl\u00ednica Biol S\u00e3o Paulo."},{"key":"3787_CR28","doi-asserted-by":"publisher","first-page":"e85785","DOI":"10.1371\/journal.pone.0085785","volume":"9","author":"C Yang","year":"2014","unstructured":"Yang C, Liu Z, Liu K, Yang P. Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression. PLoS One. 2014;9:e85785.","journal-title":"PLoS One."},{"key":"3787_CR29","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.peptides.2011.02.019","volume":"32","author":"RN Soriano","year":"2011","unstructured":"Soriano RN, Nicoli LG, Carnio EC, Branco LG. Exogenous ghrelin attenuates endotoxin fever in rats. Peptides. 2011;32:2372\u20136.","journal-title":"Peptides."},{"key":"3787_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00395-018-0671-4","volume":"113","author":"RA Eid","year":"2018","unstructured":"Eid RA, Alkhateeb MA, Eleawa S, Al-Hashem FH, Al-Shraim M, El-Kott AF, et al. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2\/STAT3 signaling. Basic Res Cardiol. 2018;113:13.","journal-title":"Basic Res Cardiol."},{"key":"3787_CR31","doi-asserted-by":"publisher","first-page":"H426","DOI":"10.1152\/ajpheart.00643.2007","volume":"294","author":"T Soeki","year":"2008","unstructured":"Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 2008;294:H426\u201332.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"3787_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.peptides.2017.10.018","volume":"99","author":"C Yang","year":"2018","unstructured":"Yang C, Liu J, Liu K, Du B, Shi K, Ding M, et al. Ghrelin suppresses cardiac fibrosis of post-myocardial infarction heart failure rats by adjusting the activin A-follistatin imbalance. Peptides. 2018;99:27\u201335.","journal-title":"Peptides."},{"key":"3787_CR33","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.peptides.2011.10.004","volume":"32","author":"MJ Yuan","year":"2011","unstructured":"Yuan MJ, Huang H, Tang YH, Wu G, Gu YW, et al. Effects of ghrelin on Cx43 regulation and electrical remodeling after myocardial infarction in rats. Peptides. 2011;32:2357\u201361.","journal-title":"Peptides."},{"key":"3787_CR34","first-page":"389","volume":"4","author":"Z Brener","year":"1962","unstructured":"Brener Z. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop S\u00e3o Paulo. 1962;4:389\u201396.","journal-title":"Rev Inst Med Trop S\u00e3o Paulo."},{"key":"3787_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clnu.2012.10.012","volume":"32","author":"CM Costa","year":"2013","unstructured":"Costa CM, da Braz\u00e3o V, Collins Kuehn C, Rodrigues Oliveira LG, do Prado J\u00fanior JC, Sala MA, et al. Zinc and pregnancy: marked changes on the immune response following zinc therapy for pregnant females challenged with Trypanosoma cruzi. Clin Nutr. 2013;32:592\u20138.","journal-title":"Clin Nutr."},{"key":"3787_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2007.04.026","volume":"43","author":"NS Bryan","year":"2007","unstructured":"Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43:645\u201357.","journal-title":"Free Radic Biol Med."},{"key":"3787_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.imbio.2018.06.001","volume":"223","author":"MRB de Freitas","year":"2018","unstructured":"de Freitas MRB, da Costa CMB, Pereira LM, do Prado JCJ, Sala MA, Abrahao AAC. The treatment with selenium increases placental parasitismin pregnant Wistar rats infected with the Y strain of Trypanosoma cruzi. Immunobiology. 2018;223:537\u201343.","journal-title":"Immunobiology."},{"key":"3787_CR38","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.158.12.5890","volume":"158","author":"MM Camargo","year":"1997","unstructured":"Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol. 1997;158:5890\u2013901.","journal-title":"J Immunol."},{"key":"3787_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","volume":"150","author":"JX Wang","year":"2007","unstructured":"Wang JX, Tang W, Shi LP, Wan J, Zhou R, Ni J, et al. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation. Br J Pharmacol. 2007;150:652\u201361.","journal-title":"Br J Pharmacol."},{"key":"3787_CR40","doi-asserted-by":"publisher","first-page":"154736","DOI":"10.1016\/j.cyto.2019.154736","volume":"121","author":"M Del Vecchio Filipin","year":"2019","unstructured":"Del Vecchio Filipin M, Brazao V, Santello FH, da Costa CMB, Paula Alonso Toldo M, de Rossetto Morais F, et al. Does Prolactin treatment trigger imunoendocrine alterations during experimental T cruzi infection? Cytokine. 2019;121:154736.","journal-title":"Cytokine."},{"key":"3787_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exppara.2014.04.012","volume":"142","author":"CM da Costa","year":"2014","unstructured":"da Costa CM, de Freitas MR, Brazao V, dos Santos CD, Sala MA, do Prado Junior JC, et al. Does l-arginine availability during the early pregnancy alters the immune response of Trypanosoma cruzi infected and pregnant Wistar rats? Exp Parasitol. 2014;142:59\u201366.","journal-title":"Exp Parasitol."},{"key":"3787_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5493\/wjem.v3.i1.1","volume":"3","author":"B Basso","year":"2013","unstructured":"Basso B. Modulation of immune response in experimental Chagas disease. World J Exp Med. 2013;3:1\u201310.","journal-title":"World J Exp Med."},{"key":"3787_CR43","doi-asserted-by":"publisher","first-page":"295394","DOI":"10.1155\/2010\/295394","volume":"2010","author":"W de Souza","year":"2010","unstructured":"de Souza W, de Carvalho TM, Barrias ES. Review on Trypanosoma cruzi: host cell interaction. Int J Cell Biol. 2010;2010:295394.","journal-title":"Int J Cell Biol."},{"key":"3787_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1590\/S1678-91992012000100005","volume":"18","author":"LRC Oliveira","year":"2012","unstructured":"Oliveira LRC, Picka MCM, Nicolete VC, Calvi SA, Marcondes-Machado J. Organ tropism during the acute and chronic phases of Trypanosoma cruzi infection in BALB\/c mice. J Venom Anim Toxins Incl Trop Dis. 2012;18:34\u201343.","journal-title":"J Venom Anim Toxins Incl Trop Dis."},{"key":"3787_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","volume":"340","author":"D Baatar","year":"2011","unstructured":"Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340:44\u201358.","journal-title":"Mol Cell Endocrinol."},{"key":"3787_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/obr.12474","volume":"18","author":"R Churm","year":"2017","unstructured":"Churm R, Davies JS, Stephens JW, Prior SL. Ghrelin function in human obesity and type 2 diabetes: a concise review. Obes Rev. 2017;18:140\u20138.","journal-title":"Obes Rev."},{"key":"3787_CR47","doi-asserted-by":"publisher","first-page":"4527980","DOI":"10.1155\/2017\/4527980","volume":"2017","author":"J Pereira","year":"2017","unstructured":"Pereira J, da Silva FC, de Moraes-Vieira PMM. The impact of Ghrelin in metabolic diseases: an immune perspective. J Diabetes Res. 2017;2017:4527980.","journal-title":"J Diabetes Res."},{"key":"3787_CR48","doi-asserted-by":"publisher","first-page":"981879","DOI":"10.1155\/2011\/981879","volume":"2011","author":"G Malafaia","year":"2011","unstructured":"Malafaia G, Talvani A. Nutritional status driving infection by Trypanosoma cruzi: lessons from experimental animals. J Trop Med. 2011;2011:981879.","journal-title":"J Trop Med."},{"key":"3787_CR49","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","volume":"9","author":"GR Acevedo","year":"2018","unstructured":"Acevedo GR, Girard MC, Gomez KA. The unsolved jigsaw puzzle of the immune response in Chagas disease. Front Immunol. 2018;9:1929.","journal-title":"Front Immunol."},{"key":"3787_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1590\/S1413-86702009000600010","volume":"13","author":"H Nahrevanian","year":"2009","unstructured":"Nahrevanian H. Involvement of nitric oxide and its up\/down stream molecules in the immunity against parasitic infections. Braz J Infect Dis. 2009;13:440\u20138.","journal-title":"Braz J Infect Dis."},{"key":"3787_CR51","doi-asserted-by":"publisher","first-page":"e1006928","DOI":"10.1371\/journal.ppat.1006928","volume":"14","author":"CN Paiva","year":"2018","unstructured":"Paiva CN, Medei E, Bozza MT. ROS and Trypanosoma cruzi: fuel to infection, poison to the heart. PLoS Pathog. 2018;14:e1006928.","journal-title":"PLoS Pathog."},{"key":"3787_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1078\/0171-2985-00091","volume":"204","author":"J Xaus","year":"2001","unstructured":"Xaus J, Comalada M, Valledor AF, Cardo M, Herrero C, Soler C, et al. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology. 2001;204:543\u201350.","journal-title":"Immunobiology."},{"key":"3787_CR53","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/eji.201646830","volume":"47","author":"CV Poncini","year":"2017","unstructured":"Poncini CV, Gonzalez-Cappa SM. Dual role of monocyte-derived dendritic cells in Trypanosoma cruzi infection. Eur J Immunol. 2017;47:1936\u201348.","journal-title":"Eur J Immunol."},{"key":"3787_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exppara.2004.03.008","volume":"106","author":"MI Antunez","year":"2004","unstructured":"Antunez MI, Cardoni RL. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection. Exp Parasitol. 2004;106:85\u201394.","journal-title":"Exp Parasitol."},{"key":"3787_CR55","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/jid.2009.30","volume":"129","author":"A Balato","year":"2009","unstructured":"Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol. 2009;129:1628\u201342.","journal-title":"J Invest Dermatol."},{"key":"3787_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1134\/S0012496616050136","volume":"470","author":"SV Shirshev","year":"2016","unstructured":"Shirshev SV, Nekrasova IV, Orlova EG, Gorbunova OL. Roles of leptin and ghrelin in the regulation of the phenotype and cytokine production by NK cells from peripheral blood. Dokl Biol Sci. 2016;470:249\u201352.","journal-title":"Dokl Biol Sci."},{"key":"3787_CR57","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1371\/journal.ppat.0020077","volume":"2","author":"DL Martin","year":"2006","unstructured":"Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, Sullivan S, et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2006;2:e77.","journal-title":"PLoS Pathog."},{"key":"3787_CR58","first-page":"243786","volume":"2014","author":"Virgilio F Dos Santos","year":"2014","unstructured":"Dos Santos Virgilio F, Pontes C, Dominguez MR, Ersching J, Rodrigues MM, Vasconcelos JR. CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development? Mediators Inflamm. 2014;2014:243786.","journal-title":"Mediators Inflamm."},{"key":"3787_CR59","doi-asserted-by":"publisher","first-page":"962047","DOI":"10.1155\/2014\/962047","volume":"2014","author":"TA da Costa","year":"2014","unstructured":"da Costa TA, Silva MV, Mendes MT, Carvalho-Costa TM, Batista LR, Lages-Silva E, et al. Immunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations. J Immunol Res. 2014;2014:962047.","journal-title":"J Immunol Res."},{"key":"3787_CR60","doi-asserted-by":"publisher","first-page":"e1002645","DOI":"10.1371\/journal.ppat.1002645","volume":"8","author":"JC Silverio","year":"2012","unstructured":"Silverio JC, Pereira IR, Cipitelli Mda C, Vinagre NF, Rodrigues MM, Gazzinelli RT, et al. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog. 2012;8:e1002645.","journal-title":"PLoS Pathog."},{"key":"3787_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mad.2015.03.011","volume":"151","author":"E Sikora","year":"2015","unstructured":"Sikora E. Activation-induced and damage-induced cell death in aging human T cells. Mech Ageing Dev. 2015;151:85\u201392.","journal-title":"Mech Ageing Dev."},{"key":"3787_CR62","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fmicb.2016.00698","volume":"7","author":"L Freire-de-Lima","year":"2016","unstructured":"Freire-de-Lima L, da Fonseca LM, da Silva VA, da Costa KM, Morrot A, Freire-de-Lima CG, et al. Modulation of cell sialoglycophenotype: a stylish mechanism adopted by Trypanosoma cruzi to ensure its persistence in the infected host. Front Microbiol. 2016;7:698.","journal-title":"Front Microbiol."},{"key":"3787_CR63","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1086\/315001","volume":"180","author":"MS Leguizamon","year":"1999","unstructured":"Leguizamon MS, Mocetti E, Garcia Rivello H, Argibay P, Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J Infect Dis. 1999;180:1398\u2013402.","journal-title":"J Infect Dis."},{"key":"3787_CR64","first-page":"Br396","volume":"16","author":"D Zhang","year":"2010","unstructured":"Zhang D, Wang W, Zhou D, Chen Y, Han L, Liu Y, et al. Ghrelin inhibits apoptosis induced by palmitate in rat aortic endothelial cells. Med Sci Monit. 2010;16:Br396\u2013403.","journal-title":"Med Sci Monit."},{"key":"3787_CR65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4110\/in.2016.16.4.242","volume":"16","author":"JH Lee","year":"2016","unstructured":"Lee JH, Kim TJ, Kim JW, Yoon JS, Kim HS, Lee KM. The anti-apoptotic effect of ghrelin on restraint stress-induced thymus atrophy in mice. Immune Netw. 2016;16:242\u20138.","journal-title":"Immune Netw."},{"key":"3787_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2007.05.013","volume":"237","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Ying B, Shi L, Fan H, Yang D, Xu D, et al. Ghrelin inhibit cell apoptosis in pancreatic beta cell line HIT-T15 via mitogen-activated protein kinase\/phosphoinositide 3-kinase pathways. Toxicology. 2007;237:194\u2013202.","journal-title":"Toxicology."},{"key":"3787_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijcard.2004.01.026","volume":"99","author":"S Tostes Jr","year":"2005","unstructured":"Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Araujo Pereira G, Rodrigues V Jr. Myocardiocyte apoptosis in heart failure in chronic Chagas disease. Int J Cardiol. 2005;99:233\u20137.","journal-title":"Int J Cardiol."},{"issue":"Suppl. 1","key":"3787_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/S0074-02762009000900033","volume":"104","author":"GA DosReis","year":"2009","unstructured":"DosReis GA, Lopes MF. The importance of apoptosis for immune regulation in Chagas disease. Mem Inst Oswaldo Cruz. 2009;104(Suppl. 1):259\u201362.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"3787_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2249.2006.03118.x","volume":"145","author":"T Lieke","year":"2006","unstructured":"Lieke T, Steeg C, Graefe SE, Fleischer B, Jacobs T. Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. Clin Exp Immunol. 2006;145:357\u201364.","journal-title":"Clin Exp Immunol."},{"key":"3787_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41\u2013101.","journal-title":"Adv Immunol."},{"key":"3787_CR71","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.12688\/f1000research.7010.1","volume":"4","author":"X Ma","year":"2015","unstructured":"Ma X, Yan W, Zheng H, Du Q, Zhang L, Ban Y, et al. Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res. 2015;4:1465.","journal-title":"F1000Res"},{"key":"3787_CR72","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.4049\/jimmunol.169.7.3637","volume":"169","author":"JK Yoo","year":"2002","unstructured":"Yoo JK, Cho JH, Lee SW, Sung YC. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase\/Akt signaling pathway. J Immunol. 2002;169:3637\u201343.","journal-title":"J Immunol."},{"key":"3787_CR73","doi-asserted-by":"publisher","first-page":"e0157175","DOI":"10.1371\/journal.pone.0157175","volume":"11","author":"A Vacaflores","year":"2016","unstructured":"Vacaflores A, Chapman NM, Harty JT, Richer MJ, Houtman JC. Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism. PLoS One. 2016;11:e0157175.","journal-title":"PLoS One."},{"key":"3787_CR74","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"3787_CR75","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.4049\/jimmunol.1800016","volume":"201","author":"B Li","year":"2018","unstructured":"Li B, Jones LL, Geiger TL. IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level RORgammat expression. J Immunol. 2018;201:2934\u201346.","journal-title":"J Immunol."},{"key":"3787_CR76","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.2036iti5","volume":"203","author":"HL Van Epps","year":"2006","unstructured":"Van Epps HL. IL-6 drives T cell proliferation. J Exp Med. 2006;203:1387.","journal-title":"J Exp Med."},{"key":"3787_CR77","doi-asserted-by":"publisher","first-page":"ftv082","DOI":"10.1093\/femspd\/ftv082","volume":"73","author":"F Cardillo","year":"2015","unstructured":"Cardillo F, de Pinho RT, Antas PR, Mengel J. Immunity and immune modulation in Trypanosoma cruzi infection. Pathog Dis. 2015;73:ftv082.","journal-title":"Pathog Dis."},{"key":"3787_CR78","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4269\/ajtmh.1993.48.161","volume":"48","author":"J Sun","year":"1993","unstructured":"Sun J, Tarleton RL. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg. 1993;48:161\u20139.","journal-title":"Am J Trop Med Hyg."},{"key":"3787_CR79","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/IAI.71.3.1185-1193.2003","volume":"71","author":"JA Gomes","year":"2003","unstructured":"Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas disease is due to a Th1-specific immune response. Infect Immun. 2003;71:1185\u201393.","journal-title":"Infect Immun."},{"key":"3787_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/clin.1997.4335","volume":"83","author":"MM Reis","year":"1997","unstructured":"Reis MM, Higuchi Mde L, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol. 1997;83:165\u201372.","journal-title":"Clin Immunol Immunopathol."},{"key":"3787_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1995-705X.144792","volume":"15","author":"MN Khatib","year":"2014","unstructured":"Khatib MN, Simkhada P, Gode D. Cardioprotective effects of ghrelin in heart failure: from gut to heart. Heart Views. 2014;15:74\u20136.","journal-title":"Heart Views."},{"key":"3787_CR82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCHEARTFAILURE.114.001167","volume":"7","author":"G Mitacchione","year":"2014","unstructured":"Mitacchione G, Powers JC, Grifoni G, Woitek F, Lam A, Ly L, et al. The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart. Circ Heart Fail. 2014;7:643\u201351.","journal-title":"Circ Heart Fail."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3787-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T19:11:51Z","timestamp":1695409911000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3787-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3787-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"6 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal manipulation protocol was approved by the local Ethics Committee (protocol number 14.1.712.53.7.).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}